NDAQ
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement,...
Read moreDetails
XTI Aerospace, Inc. Announces Offering of Common Stock Priced At-the-Market Under Nasdaq Rules
ENGLEWOOD, Colo. , Jan. 7, 2025 /PRNewswire/ -- XTI Aerospace, Inc. (Nasdaq: XTIA), ("XTI" or the "Company"), a pioneer in advanced...
Read moreDetails
S&P 500, Nasdaq slip as Treasury yields rise; NVIDIA and Tesla fall, while Getty and Shutterstock shares soar
Benchmark S&P 500 and the Nasdaq Composite fell on Tuesday as yields on Treasury bills rose, dampening sentiments across the...
Read moreDetails
Co-Diagnostics, Inc. to Participate at the Nasdaq Live from MarketSite Broadcast at Silicon Slopes 2025
SALT LAKE CITY , Jan. 7, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company...
Read moreDetails
Lifeward Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a...
Read moreDetails
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MONTREAL and CHARLOTTE, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) (the “Company” or “Milestone”), today...
Read moreDetails
Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements
TransCode shares to remain listed on Nasdaq BOSTON , Jan. 7, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the...
Read moreDetails
Here Are My Top 5 Nasdaq Stock to Buy in 2025
The Nasdaq Composite (^IXIC 1.24%) has been a great performing index, as it beat the broader S&P 500 (^GSPC 0.55%)...
Read moreDetails
Nasdaq Jumps Over 1% As Nvidia, Micron Surge: Investor Fear Eases, But Greed Index Remains In ‘Fear’ Zone
The CNN Money Fear and Greed index showed some easing in the overall fear level, while the index remained in...
Read moreDetails
Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
STATEN ISLAND, N.Y. , Jan. 6, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("we" or "Acurx" or the "Company"),...
Read moreDetails